IE
AURA icon

Israel Englander’s Aura Biosciences AURA Stock Holding History

Israel Englander’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38M Sell
617,467
-480,160
-44% -$3.44M ﹤0.01% 3114
2026
Q1 		$7.34M Buy
1,097,627
+480,289
+78% +$2.76M ﹤0.01% 2511
2025
Q4 		$3.36M Buy
617,338
+432,117
+233% +$2.57M ﹤0.01% 3432
2025
Q3 		$1.14M Buy
185,221
+61,162
+49% +$400K ﹤0.01% 4521
2025
Q2 		$777K Buy
+124,059
New +$726K ﹤0.01% 4600
2024
Q3 		– Sell
-22,188
Closed -$168K – 6081
2024
Q2 		$168K Sell
22,188
-48,529
-69% -$355K ﹤0.01% 5196
2024
Q1 		$555K Buy
+70,717
New +$586K ﹤0.01% 4745
2023
Q2 		– Sell
-31,281
Closed -$290K – 6095
2023
Q1 		$290K Buy
+31,281
New +$325K ﹤0.01% 4926
2022
Q3 		– Sell
-22,917
Closed -$325K – 7047
2022
Q2 		$325K Buy
+22,917
New +$379K ﹤0.01% 5297

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Israel Englander's AURA Position: Q2 2026 in Review

Israel Englander reduced its Aura Biosciences (AURA) stake by 44% in Q2 2026, selling an estimated $3.44M and leaving 617,467 shares worth $4.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

Israel Englander first reported a position in AURA in Q2 2022 and has held it in 9 quarters since. The position peaked at $7.34M in Q1 2026. 145 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Israel Englander held 617,467 shares of Aura Biosciences worth $4.38M as of Q2 2026.
  • Israel Englander sold 480,160 Aura Biosciences shares in Q2 2026, an estimated $3.44M.
  • Aura Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3114 holding.
  • Israel Englander first reported a position in Aura Biosciences in Q2 2022 and has held it in 9 quarters since.
  • Israel Englander's Aura Biosciences position peaked at $7.34M in Q1 2026.
  • 145 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.